How do I install the Es Ghc Hypoglycemia Safeguards skill?

Run npx skillmds@latest add dromlakhani/es-ghc-hypoglycemia-safeguards in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Es Ghc Hypoglycemia Safeguards safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: makes network calls. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Es Ghc Hypoglycemia Safeguards?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Es Ghc Hypoglycemia Safeguards free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Es Ghc Hypoglycemia Safeguards?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Es Ghc Hypoglycemia Safeguards by dromlakhani

Name: Es Ghc Hypoglycemia Safeguards
Rating: 4.666666666666667 (3 reviews)
Author: dromlakhani

Es Ghc Hypoglycemia Safeguards

This skill guides clinicians to apply safeguards—including frequent point-of-care glucose monitoring and insulin dose adjustments—to prevent hypoglycemia when tapering or discontinuing glucocorticoids in hospitalized patients. Use when encountering triggers such as "Glucocorticoid being tapered, how to avoid hypoglycemia?" or "Stopping steroids, need to avoid low blood sugar."

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Apply safeguards to avoid hypoglycemia when tapering or discontinuing glucocorticoids

STEP 1 — Gather Information

Collect current glucocorticoid type, dose, frequency, and taper plan; recent point-of-care glucose values; current insulin regimen (NPH-based or basal bolus); history of hypoglycemia; renal function.

STEP 2 — Rule In / Rule Out

Rule in: hyperglycemia (point-of-care glucose >140 mg/dL) while receiving glucocorticoids. Rule out: normoglycemia or patient not on glucocorticoids.

STEP 3 — Classify or Stratify

Classify glucocorticoid timing and duration to match insulin regimen: morning-only GC → once-daily NPH; twice-daily GC → divided NPH doses; continuous or stress-dose GC → consider basal bolus insulin.

STEP 4 — Decide

Initiate selected insulin regimen with ongoing glucose monitoring (e.g., every 4–6 hours) and preemptively reduce insulin dose as glucocorticoid taper progresses to avoid hypoglycemia.

Clinical Guardrails / Mimics / Pitfalls

Do not abruptly stop insulin without monitoring; avoid sliding-scale-only therapy; do not fail to adjust insulin as glucocorticoid dose decreases; do not ignore hypoglycemia symptoms; avoid NPH dosing that does not align with glucocorticoid pharmacokinetics.

Concrete Clinical Example

A 68‑year‑old on prednisone 40 mg daily for COPD exacerbation develops hyperglycemia (glucose 180 mg/dL). Started on NPH 10 units each morning. Prednisone tapered by 10 mg every 48 hours; glucose checked q6h and NPH reduced by 2 units with each taper step; no hypoglycemia occurred.

Source: Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278

---name: es-ghc-hypoglycemia-safeguardsdescription: This skill guides clinicians to apply safeguards—including frequent point-of-care glucose monitoring and insulin dose adjustments—to prevent hypoglycemia when tapering or discontinuing glucocorticoids in hospitalized patients. Use when encountering triggers such as "Glucocorticoid being tapered, how to avoid hypoglycemia?" or "Stopping steroids, need to avoid low blood sugar."---# Apply safeguards to avoid hypoglycemia when tapering or discontinuing glucocorticoids## STEP 1 — Gather InformationCollect current glucocorticoid type, dose, frequency, and taper plan; recent point-of-care glucose values; current insulin regimen (NPH-based or basal bolus); history of hypoglycemia; renal function.## STEP 2 — Rule In / Rule OutRule in: hyperglycemia (point-of-care glucose >140 mg/dL) while receiving glucocorticoids. Rule out: normoglycemia or patient not on glucocorticoids.## STEP 3 — Classify or StratifyClassify glucocorticoid timing and duration to match insulin regimen: morning-only GC → once-daily NPH; twice-daily GC → divided NPH doses; continuous or stress-dose GC → consider basal bolus insulin.## STEP 4 — DecideInitiate selected insulin regimen with ongoing glucose monitoring (e.g., every 4–6 hours) and preemptively reduce insulin dose as glucocorticoid taper progresses to avoid hypoglycemia.## Clinical Guardrails / Mimics / PitfallsDo not abruptly stop insulin without monitoring; avoid sliding-scale-only therapy; do not fail to adjust insulin as glucocorticoid dose decreases; do not ignore hypoglycemia symptoms; avoid NPH dosing that does not align with glucocorticoid pharmacokinetics.## Concrete Clinical ExampleA 68‑year‑old on prednisone 40 mg daily for COPD exacerbation develops hyperglycemia (glucose 180 mg/dL). Started on NPH 10 units each morning. Prednisone tapered by 10 mg every 48 hours; glucose checked q6h and NPH reduced by 2 units with each taper step; no hypoglycemia occurred.**Source:** Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, https://doi.org/10.1210/clinem/dgac278

Frequently asked questions